Chimeric Therapeutics
  1. Companies
  2. Chimeric Therapeutics
  3. Products
  4. Chimeric - Model CHM 2301 (CDH17 CAR ...

ChimericModel CHM 2301 (CDH17 CAR NK) -NK Cell Derived Allogeneic Therapies

SHARE

CHM 2301 (CDH17 CAR NK) will be developed on the next generation CORE-NK platform leveraging our CDH17 Chimeric Antigen Receptor.